The language of chromatin modification in human cancers

S Zhao, CD Allis, GG Wang - Nature Reviews Cancer, 2021 - nature.com
The genetic information of human cells is stored in the context of chromatin, which is
subjected to DNA methylation and various histone modifications. Such a 'language'of …

[HTML][HTML] APOBECs orchestrate genomic and epigenomic editing across health and disease

K Cervantes-Gracia, A Gramalla-Schmitz… - Trends in Genetics, 2021 - cell.com
APOBEC proteins can deaminate cytosine residues in DNA and RNA. This can lead to
somatic mutations, DNA breaks, RNA modifications, or DNA demethylation in a selective …

Epigenetic enzyme mutations as mediators of anti-cancer drug resistance

S Chen, Y Zhao, S Liu, J Zhang, YG Assaraf… - Drug Resistance …, 2022 - Elsevier
Despite the rapid advancement in the introduction of new drugs for cancer therapy, the
frequent emergence of drug resistance leads to disease progression or tumor recurrence …

Optimal PET-based radiomic signature construction based on the cross-combination method for predicting the survival of patients with diffuse large B-cell lymphoma

C Jiang, A Li, Y Teng, X Huang, C Ding, J Chen… - European Journal of …, 2022 - Springer
Purpose To develop and externally validate models incorporating a PET radiomics signature
(R-signature) obtained by the cross-combination method for predicting the survival of …

[HTML][HTML] GNAS knockout potentiates HDAC3 inhibition through viral mimicry-related interferon responses in lymphoma

MY He, KI Tong, T Liu, R Whittaker Hawkins, V Shelton… - Leukemia, 2024 - nature.com
Despite selective HDAC3 inhibition showing promise in a subset of lymphomas with
CREBBP mutations, wild-type tumors generally exhibit resistance. Here, using unbiased …

[HTML][HTML] Potential pathogenic impact of cow's milk consumption and bovine milk-derived exosomal MicroRNAs in diffuse large B-Cell lymphoma

BC Melnik, R Stadler, R Weiskirchen… - International Journal of …, 2023 - mdpi.com
Epidemiological evidence supports an association between cow's milk consumption and the
risk of diffuse large B-cell lymphoma (DLBCL), the most common non-Hodgkin lymphoma …

Mitochondrial pyruvate supports lymphoma proliferation by fueling a glutamate pyruvate transaminase 2–dependent glutaminolysis pathway

P Wei, AJ Bott, AA Cluntun, JT Morgan… - Science …, 2022 - science.org
The fate of pyruvate is a defining feature in many cell types. One major fate is mitochondrial
entry via the mitochondrial pyruvate carrier (MPC). We found that diffuse large B cell …

[HTML][HTML] A 9-LncRNA signature for predicting prognosis and immune response in diffuse large B-cell lymphoma

X Wang, Y Lu, Z Liu, Y Zhang, Y He, C Sun… - Frontiers in …, 2022 - frontiersin.org
Diffuse large B-cell lymphoma (DLBCL) is a biologically and clinically heterogeneous
disease that requires personalized clinical treatment. To assign patients into different risk …

[HTML][HTML] SMYD3 promotes aerobic glycolysis in diffuse large B-cell lymphoma via H3K4me3-mediated PKM2 transcription

T Tian, J Li, D Shi, Y Zeng, B Yu, X Li, P Wei… - Cell Death & …, 2022 - nature.com
Genetic abnormalities in histone methyltransferases (HMTs) frequently occur in diffuse large
B-cell lymphoma (DLBCL) and are related to its progression. SET and MYND domain …

[HTML][HTML] Taking the EZ way: Targeting enhancer of zeste homolog 2 in B-cell lymphomas

F Morschhauser, G Salles, CL Batlevi, H Tilly… - Blood reviews, 2022 - Elsevier
Enhancer of zeste homolog 2 (EZH2) is an epigenetic regulator that controls the normal
biology of germinal B cells. Overexpression or mutation of EZH2 is associated with …